AEterna Zentaris (TSE:AEZ) (NASDAQ:AEZS) is scheduled to post its quarterly earnings results after the market closes on Tuesday, March 26th. Analysts expect AEterna Zentaris to post earnings of C($0.25) per share for the quarter.

AEterna Zentaris has a 52-week low of C$1.10 and a 52-week high of C$4.04.

TRADEMARK VIOLATION NOTICE: This report was first published by Watch List News and is the sole property of of Watch List News. If you are viewing this report on another website, it was copied illegally and reposted in violation of U.S. and international copyright and trademark law. The original version of this report can be read at

AEterna Zentaris Company Profile

Aeterna Zentaris Inc is a specialty biopharmaceutical company engaged in developing and commercializing treatments in oncology, endocrinology and women’s health. The Company operates through the biopharmaceutical segment. The Company is engaged in drug development activities and in the promotion of products for others.

Further Reading: How Short Selling Works

Earnings History for AEterna Zentaris (TSE:AEZ)

Receive News & Ratings for AEterna Zentaris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AEterna Zentaris and related companies with's FREE daily email newsletter.